Medical Weight Loss for Ankeny, Iowa Residents
Ankeny, Iowa residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Ankeny through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Ankeny Residents Choose New Hope Weight Loss
Since 2020, New Hope Weight Loss has treated more than 5,400 patients from its Costa Mesa, California clinic, and Ankeny, Iowa residents get that same physician-led program by telehealth. Pricing is flat and transparent, with care overseen by Dr. Anjmun Sharma, M.D., and no insurance required to start.
From our Costa Mesa, California practice, we provide Ankeny with physician-supervised GLP-1 care entirely by telehealth. Treatment is prescribed only after Dr. Sharma's review, and medication ships discreetly to your door.
Although our clinic is physically in Costa Mesa, California, Ankeny residents receive the same physician-supervised care without leaving Iowa. We care for patients throughout the greater Ankeny area and the Des Moines metro. Compounded semaglutide and tirzepatide ship directly to your door in Iowa, and a licensed physician reviews every plan before anything is prescribed.
For Ankeny residents, being seen by video means starting this week instead of waiting for an in-person appointment. Compounded medication arrives in discreet, cold-pack packaging at your Ankeny address, usually within days.
GLP-1 Weight Loss Programs Available
Semaglutide (90-Day Metabolic Reset), from $166/mo
Our most popular program for Ankeny patients uses semaglutide, the same active ingredient found in Wegovy® and Ozempic®. In clinical trials of the branded drug, patients lost an average of 15-17% of body weight, with physician oversight and monthly dose adjustments.
Tirzepatide (Advanced Program), from $233/mo · just $7.70/day
For maximum results, tirzepatide uses a dual GLP-1/GIP mechanism that clinical trials showed can reach up to 22.5% body-weight loss.
Doctor review: $119. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.
How Telehealth Works for Ankeny
Step 1: Complete the 2-minute quiz or the medical intake form online.
Step 2: Dr. Sharma reviews your history by secure video, typically within 48 hours.
Step 3: If you are a candidate and telehealth-eligible, the state-licensed 503(a) pharmacy ships your compounded medication to your Ankeny address in cold-pack packaging. Follow-ups and dose adjustments also happen by video, no travel required.
Frequently Asked Questions, Ankeny
Does New Hope Weight Loss treat patients in Ankeny?
Yes. Although the clinic is in Costa Mesa, California, we treat Ankeny, Iowa residents by telehealth, Dr. Sharma reviews your case by secure video and compounded medication ships to your home. Eligibility is confirmed during the consultation.
Do I have to travel to get started from Ankeny?
No travel is needed. The whole process, intake, consultation, and follow-ups, is by secure video, and your medication arrives at your Ankeny address in cold-pack packaging.
What do Ankeny patients pay?
Flat nationwide pricing: $119 for the physician review, then semaglutide from $166/month and tirzepatide from $233/month, medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, with no distance surcharge.
What areas of Ankeny do you serve?
We serve patients from across Ankeny by telehealth, including the greater Ankeny area and the Des Moines metro.
What support is there for side effects for Ankeny patients?
Dr. Sharma starts Ankeny patients at a low dose and titrates slowly to limit nausea and GI effects, and your health advisor is reachable between visits by phone, WhatsApp, or message to adjust the plan if needed.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Ankeny, Iowa by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.